|
National Stock Number(NSN): 6505-01-227-5004 (6505012275004, 012275004)
| NIIN: |
01-227-5004 |
Item Name: |
MULTIVITAMIN FOR INJECTION |
INC: |
31662
|
| FSC: |
6505
|
Assignment Date: |
Mar-04-1986 |
CRIT: |
X |
IIG: |
31662 |
| ISC: |
5 |
Date Standardized: |
Mar-04-1986 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.50.5030 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
1829-35RX |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
MVI 12 LYOPHILIZED |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00053-1829-35 |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
FREEZE-DRIED POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
100.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 60.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 5.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 15.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 10.000 MILLIGRAMS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 5.000 MICROGRAMS ERGOCALCIFEROL ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 40.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 4.000 MILLIGRAMS PYRIDOXINE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS RETINOL ACTIVE INGREDIENT AND 3.600 MILLIGRAMS RIBOFLAVIN PHOSPHATE SODIUM ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
THINNER AND STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 MILLILITERS AFTER RECONSTITUTION |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
25 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
CONTAIN STABILIZERS; TO BE RECONSTITUTED WITH 5 ML OF STERILE WATER FORINJECTION USP BEFORE ADDING TO IV INFUSION FLUID |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|